Latest Breaking News On - Eva hellstr - Page 1 : comparemela.com

New method for early detection of relapse in the blood cancer disease myelodysplastic syndrome

New method for early detection of relapse in the blood cancer disease myelodysplastic syndrome
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Eva hellstrHuddinge medMagnus tobiassonKarolinska institutetDepartment of medicinePatients with myelodysplastic syndromeClinical oncology

New thesis on prognostication for patients with myelodysplastic syndrome

New thesis on prognostication for patients with myelodysplastic syndrome
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Eva hellstrMaria creignouLindberg medHuddinge medDepartment of medicineHematology unitProfessor eva hellstr

Karolinska Institute researchers discover new leukemia mechanism

Researchers in Sweden have determined a novel mechanism linking the metabolism of RNA, to the development of leukemia.

Maciej cieslaCristian bellodiEva hellstrLund universityResearchers at lund university faculty of medicineKarolinska instituteLund stem cell centerDivision of molecular hematologyLund university stem cell centerLund university facultyMolecular cellStem cell biologyMolecular hematology

Kungl Vetenskapsakademien: New knowledge about a cancer pharmaceutical led to the Sjöberg Prize

Kungl. Vetenskapsakademien: New knowledge about a cancer pharmaceutical led to the Sjöberg Prize MALMÖ, Sweden, Feb. 15, 2021 /PRNewswire/ Benjamin L. Ebert, USA, receives this year s Sjöberg Prize, worth one million US dollars, for his research into how lenalidomide works as a treatment for blood cancer. His discovery of the mechanism that promotes protein breakdown in cancer cells may be vitally important to the future development of new pharmaceuticals. The story of this pharmaceutical begins with a tragedy as, in the 1950s and 1960s, pregnant women with severe morning sickness were sometimes given thalidomide. This caused a range of birth defects and the medication was removed from the market.

United statesHong kongHarvard universityDana farber cancer instituteVastra gotalands lanMaria masucciKostenloser wertpapierhandelBenjaminl ebertEva neveliusBenjamin ebertPrnewswire benjaminl ebertEva hellstrHarvard stem cell instituteHarvard medical schoolRoyal swedish academy of sciencesPrize committee